These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25085016)
1. CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients. Li S; Fan R; Zhao XL; Wang XQ Leuk Res; 2014 Sep; 38(9):1072-8. PubMed ID: 25085016 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia. Wang H; Wang XQ; Xu XP; Lin GW Eur J Haematol; 2009 Dec; 83(6):550-8. PubMed ID: 19737310 [TBL] [Abstract][Full Text] [Related]
3. Low RPS14 expression in MDS without 5q - aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non-5q- patients. Wu L; Li X; Xu F; Zhang Z; Chang C; He Q Eur J Haematol; 2013 Jun; 90(6):486-93. PubMed ID: 23506134 [TBL] [Abstract][Full Text] [Related]
4. [An analysis of prognostic factors in 80 myelodysplastic syndrome]. Xu XQ; Wang JM; Lu SQ; Chen L; Yang JM; Zhang WP; Song XM; Xu YQ; Gong SL; Hou J; Ni X Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004 [TBL] [Abstract][Full Text] [Related]
5. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932 [TBL] [Abstract][Full Text] [Related]
6. DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome. Ribeiro HL; Maia ARS; de Oliveira RTG; Costa MB; Farias IR; de Paula Borges D; de Sousa JC; Magalhães SMM; Pinheiro RF J Clin Pathol; 2017 Nov; 70(11):970-980. PubMed ID: 28554891 [TBL] [Abstract][Full Text] [Related]
7. [mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome]. Ye F; He YM; Li GX; Wang LN; Jia N; Ma RX; Ma YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):110-5. PubMed ID: 23484702 [TBL] [Abstract][Full Text] [Related]
8. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification]. Wang XQ; Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053 [TBL] [Abstract][Full Text] [Related]
9. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595 [TBL] [Abstract][Full Text] [Related]
10. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. Huang TC; Ko BS; Tang JL; Hsu C; Chen CY; Tsay W; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713 [TBL] [Abstract][Full Text] [Related]
11. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
13. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014 [TBL] [Abstract][Full Text] [Related]
14. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
15. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia. Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes. Kim M; Hwang S; Park K; Kim SY; Lee YK; Lee DS PLoS One; 2015; 10(3):e0120602. PubMed ID: 25803272 [TBL] [Abstract][Full Text] [Related]
17. Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome. Nagasaki J; Aoyama Y; Hino M; Ido K; Ichihara H; Manabe M; Ohta T; Mugitani A Acta Haematol; 2017; 137(1):32-39. PubMed ID: 27866185 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes]. Akiba M; Matsuda A; Misumi M; Yagasaki F; Bessho M Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718 [TBL] [Abstract][Full Text] [Related]
19. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes]. Wu LY; Li X; Chang CK; Ying SX; Pu Q Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]